Oncolytic adenoviruses armed with iRGD-modified hyaluronidase, have demonstrated strong tumor-specific CD8 + T cell activation and enhanced anti-tumor effects in immunocompetent mouse models [271]. This evidence concerns the gene CD8A and neoplasm.